SHL Telemedicine (NASDAQ:SHLT) Shares Down 4.7% – Should You Sell?

Shares of SHL Telemedicine Ltd. (NASDAQ:SHLT) were down 4.7% on Thursday . The company traded as low as $2.30 and last traded at $2.38. Approximately 6,563 shares changed hands during trading, a decline of 31% from the average daily volume of 9,511 shares. The stock had previously closed at $2.50.

SHL Telemedicine Trading Down 3.7 %

The stock has a fifty day moving average of $2.53 and a two-hundred day moving average of $2.85. The company has a current ratio of 2.17, a quick ratio of 1.98 and a debt-to-equity ratio of 0.19.

Institutional Investors Weigh In On SHL Telemedicine

A hedge fund recently bought a new stake in SHL Telemedicine stock. Sphera Management Technology Funds Ltd acquired a new position in shares of SHL Telemedicine Ltd. (NASDAQ:SHLT) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 32,642 shares of the company’s stock, valued at approximately $87,000. Sphera Management Technology Funds Ltd owned about 0.20% of SHL Telemedicine as of its most recent SEC filing. 20.11% of the stock is owned by institutional investors and hedge funds.

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.